Premium Financials Agenda

Faça Login ou Cadastre-se para ter acesso completo.

Supercharge your analysis with exclusive data on more than 6000 companies.

All your companies centralized on a single place.

A powerful Screener with all companies and indicators available on the site.

All the companies you've bookmarked to learn more.

Compare up to 5 companies, using more than 900 exclusive indicators between Stocks, REITs, Ações and FIIs.

Review and analyze updated financials of more than 6.000 Stocks, REITs, FIIs and Ações.

See the most complete corporate Events Calendar in the world.

Don't miss anything regarding the companies that matter most. Join our discussions.

All material facts published in the last 90 days.

Get ahead with the best companies ranked by the community.

Price • AbbVie

ABBV

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Historical stock price chart and annual return over the past years

231%

5 years

% Total

ABBV

27%

5 years

Annual Return

ABBV